Government Executive
email Coronavirus Roundup: Possible Identity Theft in Small Business Relief Program; Biden COVID Equity Task Force to Take Up Discrimination and Xenophobia
There s a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.
On Friday, Pfizer and BioNTech submitted a biologics license application to the Food and Drug Administration for their vaccine for individuals 16 and older, which is part of the process for seeking full approval. “Following the successful delivery of more than 170 million doses to the U.S. population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Dr. Ugur Sahin, CEO and co-founder of BioNTech, in a statement. “We are pleased to work with U.S. regulators to seek approval of our COVID-19 vaccine based on our pivotal phase 3 trial and follow-up data.”